Our Brands

Wayland has developed a portfolio of medical and consumer cannabis brands for both new and experienced cannabis users.

See Our Brands

Investor Relations

Wayland represents a global growth opportunity focused on technology, brands, and partnerships.

Invest in Wayland

Stock Information

Wayland is currently listed on the Canadian Securities exchange as WAYL as a subsidiary of Maricann Group Inc.


-0.05 (CDN - Delayed. Get full stock quote here)

-2.22% Change 2.2 Close
2.19 Open 21910 Volume
2.2 High 10000 Shares issued
2.19 Low 11000 Shares outstanding

Press Releases

October 11, 2018

Wayland Group Announces $50 million Bought Deal Financing

Read More
October 10, 2018

Wayland successfully exports THC distillate from Canada to Switzerland

Read More
September 27, 2018

Wayland Announces Plans for First Retail Location in Zurich, Switzerland

Read More
January 9, 2018

Announces Closing of $40 Million Private Placement

Read More
December 14, 2017

Upsize of Previously Announced Private Placement

Read More
December 13, 2017

Announces $20 Million Private Placement

Read More
December 12, 2017

Signs Definitive Agreement with Lovell Drugs for Medical Cannabis Retail Pharmacy Initiative

Read More

Wayland is a global leader in providing the highest quality cannabis-derived medical and consumer cannabis products.

See Our Vision